Median Technologies SA (FRA:4ZG)
4.650
+0.145 (3.22%)
At close: Jan 23, 2026
Median Technologies Company Description
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally.
The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnostic tests based on imaging for the diagnosis and treatment of patients suffering from cancer; and iCRO, a central imaging service and AI-powered Imaging Lab.
Also, the company focuses on the oncology clinical trials market and the cancer patient care market. The company was founded in 2002 and is based in Valbonne, France.
Median Technologies SA
| Country | France |
| Founded | 2002 |
| Industry | Computer Integrated Systems Design |
| Employees | 211 |
| CEO | Fredrik Brag |
Contact Details
Address: 1800, Route des CrEtes Valbonne, 06560 France | |
| Phone | 33 4 93 33 37 77 |
| Website | mediantechnologies.com |
Stock Details
| Ticker Symbol | 4ZG |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 7373 |
Key Executives
| Name | Position |
|---|---|
| Fredrik Brag | Chief Executive Officer |
| Jean-Christophe Montigny | Chief Financial Officer |